PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Ethiopians and Tibetans thrive in thin air using similar physiology, but different genes

Study adds to our understanding of how high-altitude populations worldwide have evolved to be different from their low-altitude ancestors

2012-12-07
(Press-News.org) Durham, NC — Scientists say they have pinpointed genetic changes that allow some Ethiopians to live and work more than a mile and a half above sea level without getting altitude sickness. The specific genes differ from those reported previously for high-altitude Tibetans, even though both groups cope with low-oxygen in similar physiological ways, the researchers report.

If confirmed, the results may help scientists understand why some people are more vulnerable to low blood oxygen levels caused by factors other than altitude — such as asthma, sleep apnea, heart problems or anemia — and point to new ways to treat them, the researchers say.

Living with less

Lower air pressure at high altitude means fewer oxygen molecules for every breath. "At 4000 meters, every lungful of air only has 60% of the oxygen molecules that people at sea level have," said co-author Cynthia Beall of Case Western Reserve University.

To mop up scarce oxygen from thin air, travelers to high altitude compensate by making more hemoglobin, the oxygen-carrying component of human blood. But high hemoglobin comes with a cost. Over the long term, excessive hemoglobin can increase the risk of blood clots, stroke, and chronic mountain sickness, a disease characterized by thick and viscous blood.

"Altitude affects your thinking, your breathing, and your ability to sleep. But high-altitude natives don't have these problems," said Beall, who has studied high altitude adaptation in different populations in Ethiopia, Peru and Tibet for more than 20 years. "They don't wheeze like we do. Their thinking is fine. They sleep fine. They don't complain of headaches. They're able to live a healthy life, and they do it completely comfortably," she added.

How do they do it?

Research over the last four decades has revealed that people born and raised in mountainous regions cope with altitude in different ways. Native highlanders in Tibet and some in Ethiopia, for example, are able to maintain relatively low blood hemoglobin concentrations at high altitude compared to their counterparts in the Andes, a trait that makes them less susceptible to chronic mountain sickness.

Tibetans and some Ethiopians have both evolved a dampened response to low oxygen, explained study co-authors Anna Di Rienzo and Gorka Alkorta-Aranburu of the University of Chicago.

The researchers wanted to pinpoint the genetic changes that enable Ethiopians to thrive in thin air, and to see if the same genes play a role for Ethiopians as found in recent studies for Tibetans.

To find out, they analyzed the genomes of nearly 260 Ethiopian villagers belonging to two ethnic groups: the Oromo, who began settling at high altitude in the Bale Mountains of southeast Ethiopia about 500 years ago, and the Amhara, who have lived at high altitude in the Semien Mountains of northwest Ethiopia for at least 5,000 years.

Research by Beall and colleagues in the early 2000s revealed that Oromo cope with thin air in much the same way that lowlanders visiting high altitude do — i.e., by making more hemoglobin.

In contrast, Amhara highlanders — whose ancestors have inhabited mountainous regions for thousands of years longer than the Omoro — are able to maintain blood hemoglobin levels that are roughly 10% lower than Omoro living at the same altitude.

In a study to appear in the December 6, 2012 online issue of the journal PLoS Genetics, a team led by Beall, Di Rienzo and Alkorta-Aranburu analyzed both groups' DNA, which was extracted from blood and saliva samples donated by Amhara and Omoro villagers born and raised at high (3700-4000m) and low (1200-1560m) elevations.

Using a statistical technique called a genome-wide association study, the researchers scanned the genomes of highland and lowland Ethiopians from both ethnic groups in search of variants associated with hemoglobin levels in the blood.

Same solution, different genes

When they scanned the villagers' DNA, the researchers found a genetic variant associated with low hemoglobin levels in the Amhara.

This variant was located in a different region of the genome than those previously found to be associated with low hemoglobin in Tibetans. In other words, the physiological coping mechanisms shared by Amhara and Tibetans in response to life at high altitude — ie., dampened hemoglobin levels — are due to different underlying genes.

It is still unclear whether the first settlers of high altitude regions in Ethiopia and Tibet carried different genetic variants with them when they arrived, or whether different mutations occurred in these populations after they got there. But it's clear that each group followed a different evolutionary pathway.

"They have a similar physiologic solution, but that doesn't necessarily amount to a similar genetic solution," Di Rienzo said.

For the Omoro — who are relative newcomers to high altitude — the researchers also found differences between highlanders and lowlanders in DNA methylation, a chemical process that causes changes in gene activity, but doesn't necessarily alter the genetic code. While the differences aren't linked to hemoglobin levels, the results suggest that such changes may play a role in the early stages of high altitude adaptation, the researchers say.

###Other authors of the study were David Witonsky and Jonathan Pritchard of the University of Chicago, and Amha Gebremedhin of the Howard Hughes Medical Institute and Addis Ababa University in Ethiopia.

CITATION: Gorka Alkorta-Aranburu, C. M. B., David B. Witonsky, Amha Gebremedhin, Jonathan K. Pritchard, Anna Di Rienzo (2012). "The genetic architecture of adaptations to high altitude in Ethiopia." PLoS Genetics.

The National Evolutionary Synthesis Center (NESCent) is a nonprofit science center dedicated to cross-disciplinary research in evolution. Funded by the National Science Foundation, NESCent is jointly operated by Duke University, The University of North Carolina at Chapel Hill, and North Carolina State University. For more information about research and training opportunities at NESCent, visit END


ELSE PRESS RELEASES FROM THIS DATE:

The world's big trees are dying

2012-12-07
The largest living organisms on the planet, the big, old trees that harbour and sustain countless birds and other wildlife, are dying. A report by three of the world's leading ecologists in today's issue of the journal Science warns of an alarming increase in deathrates among trees 100-300 years old in many of the world's forests, woodlands, savannahs, farming areas and even in cities. "It's a worldwide problem and appears to be happening in most types of forest," says lead author Professor David Lindenmayer of the ARC Centre of Excellence for Environmental Decisions ...

The skills that make us a good partner make us a good parent

2012-12-07
December 7, 2012 - Being a good partner may make you a better parent, according to a new study. The same set of skills that we tap to be caring toward our partners is what we use to nurture our children, researchers found. The study sought to examine how caregiving plays out in families – "how one relationship affects another relationship," says Abigail Millings of the University of Bristol, lead author of the work published online this week in Personality and Social Psychology Bulletin. "We wanted to see how romantic relationships between parents might be associated ...

Obesity and overeating during menopause together promote breast tumor growth and progression

2012-12-07
PHILADELPHIA — Obese women might be able to eliminate their increased risk for postmenopausal breast cancer by taking measures during perimenopause to prevent weight gain and to therapeutically control the metabolic effects of their obesity, according to the results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research. "Obese postmenopausal women have increased risk for breast cancer and poorer clinical outcomes compared with postmenopausal women who are lean," said Paul S. MacLean, Ph.D., associate professor of ...

Existing drugs may help more breast cancer patients

Existing drugs may help more breast cancer patients
2012-12-07
More patients can benefit from highly effective breast cancer drugs that are already available, according to DNA sequencing studies by researchers at Washington University School of Medicine in St. Louis and other institutions. The investigators found that some women with the HER2 negative subtype may benefit from anti-HER2 drugs even though standard tests don't indicate they are candidates for the drugs. "These patients are going to be missed by our routine testing for HER2 positive breast cancer," says Ron Bose, MD, PhD, assistant professor of medicine. "Currently ...

Protein tied to cancer-drug resistance in mice

2012-12-07
SAN ANTONIO, TX (December 7, 2012)—Blocking a specific protein renders tumors more vulnerable to treatment in mice, suggesting new therapies could eventually achieve the same in humans, according to new research from Fox Chase Cancer Center to be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium on Friday, December 7, 2012. "Hopefully, with further testing, this research could one day result in a new therapy that blocks the effect of this protein and, in turn, boosts the effects of cancer drugs," says study author Elizabeth Hopper-Borge, PhD, Assistant ...

Study compares standard against newer treatment in women whose breast cancer has spread

2012-12-07
(Lebanon, NH, 12/7/12) — Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival. This study was presented today by Peter A. Kaufman, M.D., during the 2012 CTRC-AACR San Antonio Breast Cancer Symposium. "We didn't show a statistically significant superiority of eribulin over capecitabine, which was our goal," said Peter A. Kaufman, ...

The effect of treating institution on outcomes in head and neck cancer

2012-12-07
Alexandria, VA — Patients with head and neck cancer receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a study in the December 2012 issue of Otolaryngology–Head and Neck Surgery. "Despite similar rates of treatment completion and rate of treatment breaks between groups, patients treated in academic centers had more advanced cancer but better survival," the authors state in their conclusion. The study evaluated differences in patient characteristics, treatment, and cancer ...

Point of light

Point of light
2012-12-07
PASADENA, Calif.—As technology advances, it tends to shrink. From cell phones to laptops—powered by increasingly faster and tinier processors—everything is getting thinner and sleeker. And now light beams are getting smaller, too. Engineers at the California Institute of Technology (Caltech) have created a device that can focus light into a point just a few nanometers (billionths of a meter) across—an achievement they say may lead to next-generation applications in computing, communications, and imaging. Because light can carry greater amounts of data more efficiently ...

How the common 'cat parasite' gets into the brain

2012-12-07
"We believe that this knowledge may be important for the further understanding of complex interactions in some major public health issues, that modern science still hasn't been able to explain fully", says Antonio Barragan, researcher at the Center for Infectious Medicine at Karolinska Institutet and the Swedish Institute for Communicable Disease Control. "At the same time, it's important to emphasize that humans have lived with this parasite for many millennia, so today's carriers of Toxoplasma need not be particularly worried". The current study, which is published ...

Putting electronic cigarettes to the test

Putting electronic cigarettes to the test
2012-12-07
Electronic cigarettes are experiencing somewhat of a boom at the moment. An estimated two million people in Germany have already turned to the vapor cigarette, which many view as a healthy alternative to conventional smoking. However, a number of voices, primarily from the political sphere, are warning of possible health risks, claiming that the long-term consequences cannot yet be foreseen. Studies to date have come to mixed conclusions. There is a general lack of substantiated facts, fuelling an ongoing battle between supporters and opponents. By carrying out a new, independent ...

LAST 30 PRESS RELEASES:

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

[Press-News.org] Ethiopians and Tibetans thrive in thin air using similar physiology, but different genes
Study adds to our understanding of how high-altitude populations worldwide have evolved to be different from their low-altitude ancestors